NBIX vs PATK · P/E 45, rev $1.77B vs P/E 23, rev $2.04B
Neurocrine Biosciences Inc (NBIX) versus Patrick Industries Inc (PATK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Patrick Industries Inc (PATK) is a furnishings, fixtures & appliances company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported PATK revenue for 2026-06-28 was $2.04B. Net income was $82.9M. PATK currently screens at market cap $3.19B and trailing P/E 22.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. PATK currently screens at market cap $3.19B and trailing P/E 22.9.
Not investment advice. Open the NBIX and PATK stock pages for the full models.
Not investment advice.